Headline News about Intelgenx Technologies Corp
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/01/13/psyched_new_-_option_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/14/coins-1726618_1920_1.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/15/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/11/desperate-5011953_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/30/company_earnings_commons_-_pexels.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
January 31, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 30, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Cybin, GH Research Among Top Psychedelic Movers Of Today
January 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Psychedelic Stock Gainers And Losers From January 26, 2023
January 26, 2023
Via Benzinga
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
January 24, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
January 19, 2023
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
January 16, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023
January 13, 2023
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/11/finance_and_psychedelics_anaterate_sergeitokmakov__by_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/10/sharon-mccutcheon-8lnbxtxfgzw-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/03/cannabis_deals_geralt_lindsayfox_pixabay_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/hans-reniers-lqgjcmy5qcm-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/short_image_353.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_124.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_123.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_88.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_87.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_86.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_85.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.